BR112013015009A2 - vacina e, métodos para auxiliar na proteção de um canino e de um animal contra uma doença clínica - Google Patents

vacina e, métodos para auxiliar na proteção de um canino e de um animal contra uma doença clínica

Info

Publication number
BR112013015009A2
BR112013015009A2 BR112013015009A BR112013015009A BR112013015009A2 BR 112013015009 A2 BR112013015009 A2 BR 112013015009A2 BR 112013015009 A BR112013015009 A BR 112013015009A BR 112013015009 A BR112013015009 A BR 112013015009A BR 112013015009 A2 BR112013015009 A2 BR 112013015009A2
Authority
BR
Brazil
Prior art keywords
canine
vaccine
assist
protection
methods
Prior art date
Application number
BR112013015009A
Other languages
English (en)
Other versions
BR112013015009B1 (pt
Inventor
Gowda Jayappa Huchappa
Kevin A O' Connell
Rhonda Lafleur
Terri Lee Wasmoen
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112013015009A2 publication Critical patent/BR112013015009A2/pt
Publication of BR112013015009B1 publication Critical patent/BR112013015009B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18711Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR112013015009-2A 2010-12-22 2011-12-21 vacina para proteger um animal contra uma doença clínica decorrente de uma infecção com bordetella bronchiseptica BR112013015009B1 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201061425855P 2010-12-22 2010-12-22
US61/425855 2010-12-22
EP11152829.5 2011-02-01
EP11152829 2011-02-01
US201161556975P 2011-11-08 2011-11-08
US61/556975 2011-11-08
PCT/IB2011/003100 WO2012085642A1 (en) 2010-12-22 2011-12-21 Vaccines with live bacterial isolates for systemic administration

Publications (2)

Publication Number Publication Date
BR112013015009A2 true BR112013015009A2 (pt) 2016-08-09
BR112013015009B1 BR112013015009B1 (pt) 2020-11-10

Family

ID=43628729

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013015009-2A BR112013015009B1 (pt) 2010-12-22 2011-12-21 vacina para proteger um animal contra uma doença clínica decorrente de uma infecção com bordetella bronchiseptica

Country Status (8)

Country Link
US (1) US8821852B2 (pt)
EP (1) EP2655403A1 (pt)
JP (1) JP6145046B2 (pt)
CN (1) CN103261214B (pt)
BR (1) BR112013015009B1 (pt)
CA (2) CA2821422C (pt)
RU (1) RU2593953C2 (pt)
WO (1) WO2012085642A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106729683B (zh) * 2016-12-16 2019-12-03 青岛易邦生物工程有限公司 一种猪支气管败血波氏杆菌病疫苗
CN113924111A (zh) * 2019-01-04 2022-01-11 勃林格殷格翰动物保健美国公司 减毒的支气管败血性博德特菌菌株、包含该减毒的菌株的口服疫苗及其制备和使用方法
EP3909971A1 (en) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Whole cell livestock vaccine for respiratory diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730037D0 (en) * 1987-12-23 1988-02-03 Wellcome Found Vaccines
US5955089A (en) * 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
US5840556A (en) 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
EP0835928A1 (en) * 1996-10-11 1998-04-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Helicobacter pylori live vaccine
AUPR977601A0 (en) * 2001-12-28 2002-01-31 Delta Biotechnology Limited Defective entities and uses therefor
RU2005124130A (ru) * 2003-01-29 2006-01-20 Пфайзер Продактс Инк. (Us) Вакцины для собак против bordetella bronchiseptica
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
ME00485B (me) * 2005-10-07 2011-10-10 Zoetis Services Llc VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA
JP5245092B2 (ja) 2006-03-10 2013-07-24 アンスティテュ パストゥール ドゥ リル 百日咳に対する単一用量ワクチンとしての生弱毒化ボルデテラ株
WO2008118592A2 (en) 2007-02-23 2008-10-02 The Penn State Research Foundation Use of an avirulent bordetella mutant as a live vaccine vector
KR20080082883A (ko) * 2007-03-09 2008-09-12 전남대학교산학협력단 약독화된 보르데텔라 브론키셉티카 (bbs) 균주 및 그의제조 방법, 그를 포함하는 면역원성 조성물 및 그를 이용한포유동물의 bbs 감염증을 치료 또는 예방하는 방법
TWI468157B (zh) 2009-04-29 2015-01-11 Intervet Int Bv 形成錠劑的方法,進行該方法的系統及包含該錠劑的包裝物
CN101575586B (zh) * 2009-05-31 2011-01-19 华中农业大学 一种支气管败血波氏杆菌基因缺失疫苗及应用

Also Published As

Publication number Publication date
CN103261214B (zh) 2016-10-26
CA3219727A1 (en) 2012-06-28
RU2593953C2 (ru) 2016-08-10
EP2655403A1 (en) 2013-10-30
JP6145046B2 (ja) 2017-06-07
JP2014500302A (ja) 2014-01-09
WO2012085642A1 (en) 2012-06-28
RU2013133856A (ru) 2015-01-27
BR112013015009B1 (pt) 2020-11-10
CN103261214A (zh) 2013-08-21
CA2821422C (en) 2024-01-02
US20130273100A1 (en) 2013-10-17
CA2821422A1 (en) 2012-06-28
US8821852B2 (en) 2014-09-02

Similar Documents

Publication Publication Date Title
IL265707A (en) Pharmaceutical preparations containing human antibodies to pcsk9
CO6980640A2 (es) Implemento para el cuidado oral empacado
BR112012004176A2 (pt) implemento para cuidado oral
BR302012000974S1 (pt) Configuração aplicada em implemento para cuidado oral
BR112013016211A2 (pt) implemento para higiene oral
BRPI1012066A2 (pt) composição para o cuidado oral , e, métodos para preparar a composição para o cuidado oral e para administrar um composto de zinco a um indivíduo animal ou humano em necessidade do mesmo
BR112014009634A2 (pt) preparação e agente terapêutico
BR112013013405A2 (pt) embalagem, matriz para formar um carregador, e método para formar uma embalagem
BR112012005398A2 (pt) dispositivo implantável, e, método para administrar lidocaína na bexiga de um paciente
BR302013000208S1 (pt) Configuração aplicada a uma embalagem para implemento de higiene oral
CO6801754A2 (es) Una composición farmacéutica para tratar una enfermedad en la cavidad oral que comprende rebamipida
BR112013031760A2 (pt) vacina contra coronavírus canino
BR112013023431A2 (pt) modelo dental e dentes de modelo
BR112013015988A2 (pt) aparelho dental para restringir a língua
BR112014013694A2 (pt) método para tratar uma doença, e, kit
BR302013000209S1 (pt) Configuração aplicada a uma embalagem para implemento de higiene oral
BR112013029637A2 (pt) composições para cuidados orais
BR112013014812A2 (pt) implemento para higiene bucal
BR112013015009A2 (pt) vacina e, métodos para auxiliar na proteção de um canino e de um animal contra uma doença clínica
HK1211790A1 (en) Animal model of krabbes disease
BRPI0920124A2 (pt) produto farmacêutico para aumentar a dose de vacina contra alergia
BR112015002984A2 (pt) composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico.
ZA201301421B (en) Animal model for the evaluation of the efficacy of an hiv vaccine
BR112013016467A2 (pt) composições e métodos para identificação e diferenciação de componentes do vírus das vacinas contra a febre dos transportes multivalentes
CL2015001100A1 (es) Método y alimentación de ganado para mejorar las características de la canal

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/12/2011, OBSERVADAS AS CONDICOES LEGAIS.